Background
Methods
Experimental Procedures
Heart perfusion and analysis of haemodynamic function
Model of Surgically-Induced Heart Failure
Experimental Groups
Assays
PKC activity
Glycogen content in myocardium
LDH activity
Infarct Size
Statistical Analysis
Results
Optimization of the protocol of Iso/Ade treatment with a clinically relevant dose of Isoproterenol
Parameters | Preiscaemic equilibration (n = 34) | Reperfusion (Percentage preischaemic value) | ||||
---|---|---|---|---|---|---|
Control (n = 7) | Iso/Ade-0 (n = 10) | Iso/Ade-5 (n = 9) | Iso/Ade-10 (n = 8) | |||
LVDP (mmHg) | 75.1 ± 2.5 | % of initial values | 29.4 ± 5.7 | 88.9 ± 7.2 *** | 73.6 ± 8.3 * | 78.3 ± 14.9 * |
HR (beat/min) | 277.6 ± 4.2 | 102.5 ± 11.4 | 86.9 ± 5.6 | 94.5 ± 3.2 | 71.6 ± 8.9 | |
RPP (mmHg · beat/min) | 20802 ± 713 | 28.5 ± 5.2 | 76.3 ± 6.9 *** | 68.5 ± 7.0 ** | 73.3 ± 10.5 ** | |
+dP/dt (mmHg/s) | 3082 ± 117 | 30.2 ± 2.5 | 65.2 ± 6.9 ** | 58.6 ± 5.3 * | 60.4 ± 8.5 * | |
-dP/dt (mmHg/s) | −2027 ± 83 | 42.7 ± 4.4 | 85.5 ± 7.2 ** | 65.6 ± 8.2 | 71.5 ± 8.9 | |
Maximal LVEDP at Reperfusion (mmHg) | - | 98.7 ± 7.5 | 50.0 ± 4.4 *** | 62.1 ± 8.2 ** | 63.2 ± 6.5 ** |
Effect of the combined treatment with Iso, Ade and cyclosporine A on ischaemia/reperfusion injury
Parameters | Pre-Ischaemia (n = 24) | Reperfusion (Percentage preischaemic value) | ||||
---|---|---|---|---|---|---|
Control (n = 7) | Iso/Ade (n = 6) | CsA (n = 5) | Iso/Ade + CsA (n = 6) | |||
LVDP (mmHg) | 75.8 ± 2.9 | % of initial values | 39.0 ± 6.6 | 100.5 ± 14.2 * | 89.5 ± 14.4 | 97.8 ± 16.9 * |
HR (beat/min) | 288.3 ± 3.9 | 96.0 ± 3.5 | 93.1 ± 3.1 | 99.3 ± 4.7 | 102.9 ± 2.9 | |
RPP (mmHg · beat/min) | 21854 ± 889 | 38.8 ± 7.5 | 93.0 ± 12.0 ** | 86.3 ± 13.3 * | 100.3 ± 11.2 ** | |
+dP/dt (mmHg/s) | 2969 ± 94 | 34.2 ± 4.6 | 81.3 ± 12.3 * | 66.4 ± 13.3 | 87.2 ± 14.3 * | |
-dP/dt (mmHg/s) | −2074 ± 84 | 42.7 ± 4.7 | 93.6 ± 12.4 ** | 71.7 ± 8.3 | 90.8 ± 13.5 * | |
Maximal LVEDP at Reperfusion (mmHg) | - | 98.6 ± 5.6 | 53.9 ± 13.2 ** | 78.2 ± 8.6 | 65.9 ± 4.2 * |
Consecutive Iso/Ade treatment protects hearts with surgically-induced heart failure
Procedure | BW (g) | HW (g) | LW (g) | Tibia (mm) | HW/BW (mg/g) | LW/BW (mg/g) | HW/Tibia (mg/mm) | LW/Tibia (mg/mm) |
---|---|---|---|---|---|---|---|---|
Sham (n = 6) | 502.2 ± 8.0 | 1.56 ± 0.04 | 1.62 ± 0.04 | 46.7 ± 0.5 | 3.1 ± 0.1 | 3.2 ± 0.1 | 3.3 ± 0.1 | 3.5 ± 0.1 |
CAL (n = 5) | 491.4 ± 25.6 | 2.42 ± 0.20 ** | 1.97 ± 0.13 * | 46.1 ± 0.6 | 4.9 ± 0.4 *** | 4.0 ± 0.1 *** | 5.3 ± 0.4 *** | 4.3 ± 0.2 ** |
Parameters | Pre-Ischaemia (n = 20) | Reperfusion (Percentage preischaemic value) | ||||
---|---|---|---|---|---|---|
Control SO (n = 5) | Iso/Ade SO (n = 5) | Control CAL (n = 5) | Iso/Ade CAL (n = 5) | |||
LVDP (mmHg) | 75.2 ± 4.3 | % of initial values | 24.1 ± 3.9 | 65.4 ± 9.1 * | 20.7 ± 4.0 | 69.6 ± 15.2 ** |
HR (beat/min) | 271.1 ± 7.8 | 89.1 ± 19.4 | 107.5 ± 7.6 | 94.4 ± 3.0 | 99.0 ± 4.5 | |
RPP (mmHg · beat/min) | 20454 ± 1333 | 22.5 ± 5.9 | 66.3 ± 9.8 * | 19.7 ± 4.0 | 69.0 ± 16.3 * | |
+dP/dt (mmHg/s) | 2596 ± 154 | 31.7 ± 3.3 | 82.4 ± 20.8 | 66.3 ± 15.8 | 87.2 ± 14.3 | |
-dP/dt (mmHg/s) | −1868 ± 138 | 37.8 ± 2.7 | 86.5 ± 22.1 ** | 40.4 ± 4.5 | 77.0 ± 14.3 | |
Maximal LVEDP at Reperfusion (mmHg) | - | 91.9 ± 19.1 | 28.7 ± 12.2 * | 67.3 ± 9.9 | 20.2 ± 21.1 |